Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1824 (LINC01824) is a member of the long non-coding RNA (lncRNA) class, specifically falling under long intergenic non-coding RNAs (lincRNAs), which are defined as RNA transcripts longer than 200 nucleotides and located between protein-coding genes on the genome[1][5]. LINC01824 does not encode a protein; rather, like other lincRNAs, it is presumed to regulate gene expression at the epigenetic, transcriptional, and post-transcriptional level, although little is published about its specific function, biological role, or clinical relevance[1][5]. As of now, there is no direct evidence identifying LINC01824 as a therapeutic target, biomarker, or as having a well-characterized function or disease association[1][5]. Its aliases include LINC01824, ENSG00000226488 (Ensembl), and 107985844 (NCBI Gene)[1][5]. If you require information on the general mechanistic roles of lincRNAs, they can participate in chromatin remodeling, transcriptional regulation, and modulating mRNA stability, but such functions for LINC01824 specifically have not yet been demonstrated[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1824 (LINC01824).